cathepsin-g and 4-toluenesulfonyl-fluoride

cathepsin-g has been researched along with 4-toluenesulfonyl-fluoride* in 2 studies

Other Studies

2 other study(ies) available for cathepsin-g and 4-toluenesulfonyl-fluoride

ArticleYear
Cathepsin G enhances human natural killer cytotoxicity.
    Immunology, 1998, Volume: 93, Issue:1

    Cathepsin G is a serine protease located in the azurophil granules of neutrophils. In this study, we investigated the effect of cathepsin G on the functions of human natural killer (NK) cells in vitro. Cathepsin G enhanced NK cytotoxicity rapidly in a dose-dependent fashion. The ability to augment NK cytotoxicity was markedly reduced in the presence of the inhibitor, phenylmethanesulphonyl fluoride (PMSF) or chymostatin, demonstrating that the proteolytic activity of cathepsin G is essential for the induction of NK cytotoxicity. Granulocyte exocytosis is required for NK cell-dependent target killing. Cathepsin G induced the release of the granule enzyme, N-acetyl-beta-D-glucosaminidase, from human NK cells. Moreover, an increase in the cytosolic-free Ca2+ concentration was observed in NK cells after stimulation with cathepsin G. When human granulocytes were stimulated with cytochalasin B and N-formyl-methionyl-leucyl-phenylalanine (fMLP), cathepsin G was released. The cathepsin G released from granulocytes also caused enhancement of NK cytotoxicity. In the presence of serine protease inhibitor the supernatant including cathepsin G obtained from stimulated granulocytes did not enhance NK cytotoxicity, but the stimulated granulocytes did. Highly purified human NK cells treated with cathepsin G enhanced NK cytotoxicity, but NK-depleted lymphocytes did not, demonstrating that cathepsin G regulates NK cytotoxicity independently of other factors. We have shown recently that human cathepsin G binds to human NK cells. These combined data indicate that cathepsin G released from granulocytes binds to NK cells and augments NK cytotoxicity through its protease activity.

    Topics: Calcium; Cathepsin G; Cathepsins; Cytotoxicity, Immunologic; Dose-Response Relationship, Drug; Exocytosis; Granulocytes; Humans; Killer Cells, Natural; Oligopeptides; Serine Endopeptidases; Serine Proteinase Inhibitors; Tosyl Compounds; Tumor Cells, Cultured

1998
SepA, the 110 kDa protein secreted by Shigella flexneri: two-domain structure and proteolytic activity.
    Microbiology (Reading, England), 1998, Volume: 144 ( Pt 7)

    Shigellosis is characterized by a strong inflammatory response which is induced by bacteria invading the colonic mucosa. Characterization of a sepA mutant indicated that SepA, the major protein secreted by Shigella flexneri growing in laboratory media, might be involved in invasion and destruction of the host intestinal epithelium. The sequence of the first 500 residues of mature SepA (110 kDa) is homologous to that of the N-terminal region of IgA1 proteases. To investigate the potential proteolytic activity of SepA, the activity of the purified protein on a wide range of synthetic peptides was tested. SepA hydrolysed several of these substrates and the activity was inhibited by PMSF. Several peptides which were hydrolysed by SepA have been described as specific substrates for cathepsin G, a serine protease produced by polymorphonuclear leukocytes that was proposed to play a role in inflammation. However, unlike cathepsin G, SepA degraded neither fibronectin nor angiotensin I and had no effect on aggregation of human platelets. In addition, analysis of SepA hydrolysis by proteinase K suggested that the protein is composed of two domains of about 450 residues separated by a hinge region of 100 residues. The 47 kDa N-terminal domain was stable and endowed with proteolytic activity.

    Topics: Angiotensin I; Bacterial Proteins; Cathepsin G; Cathepsins; Chromatography, Liquid; Cloning, Molecular; Electrophoresis, Polyacrylamide Gel; Endopeptidase K; Fibronectins; Humans; Mutation; Protease Inhibitors; Serine Endopeptidases; Shigella flexneri; Tosyl Compounds

1998